LATEST NEWS
Vedolizumab Shown To Be Effective For Treating Inflammatory Bowel Diseases
The results from two phase 3 studies evaluating vedolizumab for the treatment of ulcerative colitis and Crohn's disease have been published.
Childhood Obesity Linked To Emotional Issues
Schoolchildren suffering from obesity are at higher risk of developing psychological problems than their slimmer counterparts, according to a new study in Taiwan.
Diabetes Sufferers May Have Abnormal Gut Taste Mechanisms
Researchers have discovered that the way the gut "tastes" sweet food may be defective in sufferers of type 2 diabetes.
50,000 Kids To Get Self-Adjusting Eyeglasses
The Child ViSion project will begin handing out the first 50,000 pairs of self-adjusting glasses to help near-sighted teenagers in Asia.
High Doses Of Epilepsy Drug Linked To Birth Defects, Study
High doses of a common epilepsy drug leads to an increased risk of having a baby with specific birth defects, according to a new study.
Space Ginseng, Anyone?
Ginseng, a herb with a long history in traditional Chinese medicine, has made its first trip to space and back aboard the Shenzhou-10 spacecraft.
Adimab Partners Innovent On Monoclonal Antibody Drug Research
Adimab, LLC and Innovent have signed a partnership for the discovery, development and commercialization of an antibody-based therapeutic program.
Sirona Biochem Signs LOI With Wanbang Pharma
Sirona Biochem has signed a LOI with Wanbang Pharma to develop and commercialize its SGLT2 inhibitor in China.
MicuRx Raises US$25m For US-China Antibiotic Clinical Trial
MicuRx Pharma has raised US$25 million in Series B financing to carry out clinical trials on its MRX-I antibiotic candidate.
